KAM
BSTG

Kazazian Asset Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Kazazian Asset Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,700
Closed -$25K – 114
2014
Q4 		$25K Buy
+7,700
New +$38.1K 0.02% 86

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Kazazian Asset Management's BSTG Position: Q1 2015 in Review

Kazazian Asset Management sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2015, closing a stake of 7,700 shares — an estimated $25K sold.

Kazazian Asset Management first reported a position in BSTG in Q4 2014 and held it in 1 quarter. The position peaked at $25K in Q4 2014. 37 funds tracked by Wall St. Rank hold BSTG as of Q1 2015.

  • Kazazian Asset Management reported no remaining Biostage, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Kazazian Asset Management sold 7,700 Biostage, Inc. Common Stock shares in Q1 2015, an estimated $25K.
  • Kazazian Asset Management first reported a position in Biostage, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Kazazian Asset Management's Biostage, Inc. Common Stock position peaked at $25K in Q4 2014.
  • 37 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2015.

Based on Kazazian Asset Management's 13F filing for Q1 2015, filed 11 May 2015.